Cattedra di Gastroenterologia, Dipartimento di Scienze Mediche and Istituto di Biometria e Statistica Medica, Università degli Studi and Fondazione IRCCS Ospedale Maggiore Policlinico, Mangiagalli, Regina Elena, Milan, Italy.
Aliment Pharmacol Ther. 2010 Mar;31(6):658-65. doi: 10.1111/j.1365-2036.2009.04217.x. Epub 2009 Dec 10.
Long-term follow-up studies of achalasia after pneumatic dilation, mostly retrospective, have shown variable results.
To examine the outcome of achalasia after pneumatic dilation using a prospective follow-up programme.
One or two dilations (first dilation treatment) in 77 patients to achieve stable (>1 year) remission and patients followed up with yearly clinical and manometric assessments. Endoscopy, pH monitoring and barium swallow were also performed.
A total of 69 patients achieved stable remission and were followed up for 5.6 years (3-10.7) [median (IQ range)], whereas six patients underwent cardiomyotomy and two experienced a perforation. Twelve of the 69 patients relapsed after 2.6 years (1.7-5.1): nine of 12 underwent one to two further dilations. Six-year remission rate (by Kaplan-Meyer estimates) was 82% after first dilation treatment and 96% after all dilations. Continuous antisecretory treatment was clinically needed in 16%, oesophagitis present in 7% and reflux pathological in 28% of the patients. Beneficial effects of dilation on oesophageal motility and on diameter of the oesophageal body at barium swallow were maintained during follow-up.
A management strategy including sessions of pneumatic dilation until stable remission and a standardized follow-up is highly successful in the long term. Gastro-oesophageal reflux is clinically relevant in a minority of patients.
经皮球囊扩张治疗后的贲门失弛缓症的长期随访研究多为回顾性研究,结果不一。
采用前瞻性随访方案来检查经皮球囊扩张治疗后的贲门失弛缓症的结果。
77 例患者接受了 1 次或 2 次扩张(首次扩张治疗),以达到稳定的缓解(>1 年),并对患者进行了每年的临床和测压评估。还进行了内镜检查、pH 监测和钡餐检查。
共有 69 例患者达到了稳定缓解,并随访了 5.6 年(3-10.7)[中位数(IQR 范围)],而 6 例患者接受了贲门肌切开术,2 例患者发生了穿孔。69 例患者中有 12 例在 2.6 年后复发:其中 9 例接受了 1 至 2 次进一步的扩张。首次扩张治疗后 6 年的缓解率(根据 Kaplan-Meier 估计)为 82%,所有扩张治疗后的缓解率为 96%。16%的患者需要持续抗分泌治疗,7%的患者存在食管炎,28%的患者存在病理性反流。扩张对食管运动和钡餐食管体直径的有益影响在随访期间得以维持。
包括数次经皮球囊扩张以达到稳定缓解以及标准化随访的治疗策略在长期内具有很高的成功率。胃食管反流在少数患者中具有临床意义。